Although having advantages such as good mechanical property and rapid curing, the poor absorption and biological activity of hydroxyapatite (HA)/poly(methylmethacrylate) (PMMA) bone cement limits its clinical application. Therefore, it is of vital importance to improve the integration and the biological activity of HA/PMMA bone cement. In this study, spherical and rod-like HA/PMMA bone cement with different content of P(MMA-co-MPS) were chosen to enhance its interface bioactivity. The content of P(MMA-co-MPS) on the surface of HA was 12, 30, 15, and 28%, respectively, corresponding to 0.3 r-HA, 1.5 r-HA, 0.3 s-HA, and 1.5 s-HA, whose calcium-to-phosphorus (Ca/P) ratios were 1.62, 1.5, 1.65, and 1.53, respectively, and were confirmed by energy dispersive spectroscopy. From scanning electron microscope, we found that the spherical HA (s-HA) promotes the biomineralization on the surface of PMMA than rod-like HA (r-HA). In addition, cell experiments in vitro showed that s-HA/PMMA with lower modification degree (0.3) of P(MMA-co-MPS) results in more cell adhesion and more evenly distributed on surface spreading while observed under laser confocal microscope. Meanwhile, in vitro, cell proliferation and alkaline phosphatase activity indicated that s-HA/PMMA bone cement promotes early osteogenic differentiation of rBMSCs in a deeper extent than r-HA/PMMA, demonstrating that 0.3 s-HA/PMMA provides a favorable theoretical basis for the further clinical application of HA/PMMA bone cement as an optimized bone repair material.